Recent Finacing
Recent Raise
Clover Biopharmaceuticals is a clinical-stage biotech developing trimerized fusion-protein therapeutics and vaccines using its proprietary Trimer-Tag platform, operating cGMP biomanufacturing and advancing oncology, autoimmune, biosimilar and COVID-19 programs.
